Retour aux projets

18373.1 PFLS-LS

18373.1 PFLS-LS

Résumé

Optogenetic stimulation of glutamatergic transmission to study a new class of allosteric modulators in anxiety disorders and substance abuse

Textes supplémentaires

Abstract

The objective is to use an optogenetic approach to study the therapeutic potential of allosteric modulation of glutamatergic transmission (mGluR4 & 7) in the amygdala for the treatment of anxiety disorders and substance abuse. We will explore this in animal models of posttraumatic stress disorder and reward/motivation. We aim to improve efficacy and specificity of allosteric glutamatergic modulators by assessing their effects on stimulation of specific pathways related to these therapeutic areas.

Participants

Tim Dyer

Wirtschaftspartner

Tim.Dyer@addexpharma.com

Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH

Ron Stoop

Kontaktperson

rstoop@unil.ch

CHUV Centre Hospitalier Universitaire Va Ron Stoop Route de Cery 1008 Prilly VD CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2018-09-30
Coûts totaux approuvés
CHF 666240.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%